Index Terms Starting With 'M' (Mastocytosis)

  • Mastocytosis D47.09
    ICD-10-CM Diagnosis Code D47.09

    Other mast cell neoplasms of uncertain behavior

      2018 - New Code 2019 2020 2021 Billable/Specific Code
    Applicable To
    • Extracutaneous mastocytoma
    • Mast cell tumor NOS
    • Mastocytoma NOS
    • Mastocytosis NOS

    • aggressive systemic C96.21
      ICD-10-CM Diagnosis Code C96.21

      Aggressive systemic mastocytosis

        2018 - New Code 2019 2020 2021 Billable/Specific Code
    • cutaneous (diffuse) (maculopapular) D47.01
      ICD-10-CM Diagnosis Code D47.01

      Cutaneous mastocytosis

        2018 - New Code 2019 2020 2021 Billable/Specific Code
      Applicable To
      • Diffuse cutaneous mastocytosis
      • Maculopapular cutaneous mastocytosis
      • Solitary mastocytoma
      • Telangiectasia macularis eruptiva perstans
      • Urticaria pigmentosa
      Type 1 Excludes
      • congenital (diffuse) (maculopapular) cutaneous mastocytosis (Q82.2)
      • congenital urticaria pigmentosa (Q82.2)
      • extracutaneous mastocytoma (D47.09)
      • congenital Q82.2
        ICD-10-CM Diagnosis Code Q82.2

        Congenital cutaneous mastocytosis

          2016 2017 2018 - Revised Code 2019 2020 2021 Billable/Specific Code POA Exempt
        Applicable To
        • Congenital diffuse cutaneous mastocytosis
        • Congenital maculopapular cutaneous mastocytosis
        • Congenital urticaria pigmentosa
        Type 1 Excludes
        • cutaneous mastocytosis NOS (D47.01)
        • diffuse cutaneous mastocytosis (with onset after newborn period) (D47.01)
        • malignant mastocytosis (C96.2-)
        • systemic mastocytosis (D47.02)
        • urticaria pigmentosa (non-congenital) (with onset after newborn period) (D47.01)
      • of neonatal onset Q82.2
        ICD-10-CM Diagnosis Code Q82.2

        Congenital cutaneous mastocytosis

          2016 2017 2018 - Revised Code 2019 2020 2021 Billable/Specific Code POA Exempt
        Applicable To
        • Congenital diffuse cutaneous mastocytosis
        • Congenital maculopapular cutaneous mastocytosis
        • Congenital urticaria pigmentosa
        Type 1 Excludes
        • cutaneous mastocytosis NOS (D47.01)
        • diffuse cutaneous mastocytosis (with onset after newborn period) (D47.01)
        • malignant mastocytosis (C96.2-)
        • systemic mastocytosis (D47.02)
        • urticaria pigmentosa (non-congenital) (with onset after newborn period) (D47.01)
      • of newborn onset Q82.2
        ICD-10-CM Diagnosis Code Q82.2

        Congenital cutaneous mastocytosis

          2016 2017 2018 - Revised Code 2019 2020 2021 Billable/Specific Code POA Exempt
        Applicable To
        • Congenital diffuse cutaneous mastocytosis
        • Congenital maculopapular cutaneous mastocytosis
        • Congenital urticaria pigmentosa
        Type 1 Excludes
        • cutaneous mastocytosis NOS (D47.01)
        • diffuse cutaneous mastocytosis (with onset after newborn period) (D47.01)
        • malignant mastocytosis (C96.2-)
        • systemic mastocytosis (D47.02)
        • urticaria pigmentosa (non-congenital) (with onset after newborn period) (D47.01)
    • indolent systemic D47.02
      ICD-10-CM Diagnosis Code D47.02

      Systemic mastocytosis

        2018 - New Code 2019 2020 2021 Billable/Specific Code
      Applicable To
      • Indolent systemic mastocytosis
      • Isolated bone marrow mastocytosis
      • Smoldering systemic mastocytosis
      • Systemic mastocytosis, with an associated hematological non-mast cell lineage disease (SM-AHNMD)
      Code Also
      • , if applicable, any associated hematological non-mast cell lineage disease, such as:
      • acute myeloid leukemia (C92.6-, C92.A-)
      • chronic myelomonocytic leukemia (C93.1-)
      • essential thrombocytosis (D47.3)
      • hypereosinophilic syndrome (D72.1)
      • myelodysplastic syndrome (D46.9)
      • myeloproliferative syndrome (D47.1)
      • non-Hodgkin lymphoma (C82-C85)
      • plasma cell myeloma (C90.0-)
      • polycythemia vera (D45)
      Type 1 Excludes
      • aggressive systemic mastocytosis (C96.21)
      • mast cell leukemia (C94.3-)
    • isolated bone marrow D47.02
      ICD-10-CM Diagnosis Code D47.02

      Systemic mastocytosis

        2018 - New Code 2019 2020 2021 Billable/Specific Code
      Applicable To
      • Indolent systemic mastocytosis
      • Isolated bone marrow mastocytosis
      • Smoldering systemic mastocytosis
      • Systemic mastocytosis, with an associated hematological non-mast cell lineage disease (SM-AHNMD)
      Code Also
      • , if applicable, any associated hematological non-mast cell lineage disease, such as:
      • acute myeloid leukemia (C92.6-, C92.A-)
      • chronic myelomonocytic leukemia (C93.1-)
      • essential thrombocytosis (D47.3)
      • hypereosinophilic syndrome (D72.1)
      • myelodysplastic syndrome (D46.9)
      • myeloproliferative syndrome (D47.1)
      • non-Hodgkin lymphoma (C82-C85)
      • plasma cell myeloma (C90.0-)
      • polycythemia vera (D45)
      Type 1 Excludes
      • aggressive systemic mastocytosis (C96.21)
      • mast cell leukemia (C94.3-)
    • malignant C96.29
      ICD-10-CM Diagnosis Code C96.29

      Other malignant mast cell neoplasm

        2018 - New Code 2019 2020 2021 Billable/Specific Code
    • systemic (indolent) (smoldering)
      • with an associated hematological non-mast cell lineage disease D47.02
        (SM-AHNMD)
        ICD-10-CM Diagnosis Code D47.02

        Systemic mastocytosis

          2018 - New Code 2019 2020 2021 Billable/Specific Code
        Applicable To
        • Indolent systemic mastocytosis
        • Isolated bone marrow mastocytosis
        • Smoldering systemic mastocytosis
        • Systemic mastocytosis, with an associated hematological non-mast cell lineage disease (SM-AHNMD)
        Code Also
        • , if applicable, any associated hematological non-mast cell lineage disease, such as:
        • acute myeloid leukemia (C92.6-, C92.A-)
        • chronic myelomonocytic leukemia (C93.1-)
        • essential thrombocytosis (D47.3)
        • hypereosinophilic syndrome (D72.1)
        • myelodysplastic syndrome (D46.9)
        • myeloproliferative syndrome (D47.1)
        • non-Hodgkin lymphoma (C82-C85)
        • plasma cell myeloma (C90.0-)
        • polycythemia vera (D45)
        Type 1 Excludes
        • aggressive systemic mastocytosis (C96.21)
        • mast cell leukemia (C94.3-)